Snus is tobacco; a nicotine pouch is not. That one fact decides the legal status, the toxicant profile and the tax treatment of each. What it does not decide is how much nicotine you get: per gram of pouch material the two carry almost identical amounts, and the difference in what reaches you comes from mass and format, not from the tobacco.
Almost everything written about this comparison is either a brand’s marketing or a restatement of the EU ban. The interesting differences are elsewhere, and three of them surprised me when I went through the primary documents: the word for a nicotine pouch does not appear in EU or UK tobacco law at all; a tobacco-free pouch is a federally regulated tobacco product in the United States that pays no federal tobacco tax; and FDA has now granted a tobacco-free pouch the same reduced-risk claim, word for word, that it granted Swedish snus.
Both exist in law, but only one of them is named
Start with the EU, because the ban is what everyone has heard of. The Tobacco Products Directive defines what it prohibits: “tobacco for oral use’ means all tobacco products for oral use, except those intended to be inhaled or chewed, made wholly or partly of tobacco, in powder or in particulate form or in any combination of those forms, particularly those presented in sachet portions or porous sachets;” and Article 17 then says “Member States shall prohibit the placing on the market of tobacco for oral use, without prejudice to Article 151 of the Act of Accession of Austria, Finland and Sweden.”
That last clause is the whole Swedish exemption, and the Directive explains it in its own recitals: “Article 151 of the Act of Accession of Austria, Finland and Sweden grants Sweden a derogation from the prohibition.” Sweden did not negotiate a snus-specific carve-out inside the tobacco rules; it negotiated a derogation in its 1994 accession treaty, and every subsequent directive has deferred to it. I have written the longer version of that history in why snus is banned across the EU but legal in Sweden.
Now the part that is rarely stated. I searched the whole of the Directive and the whole of the UK’s implementing regulations for the vocabulary of a nicotine pouch. nicotine pouch: zero hits in both. snus: zero hits in both. tobacco-free: zero. The word “pouch” does appear — eight times in the Directive, sixteen in the UK instrument — and every single occurrence is about a bag of rolling tobacco: “‘pouch’ means a unit packet of roll-your own tobacco, either in the form of a rectangular pocket with a flap that covers the opening or in the form of a standing pouch;”.
So in EU and UK tobacco law, “pouch” means a tobacco bag, and the product category that half of Europe now argues about is simply absent. That is why national rules on pouches differ so wildly from one member state to the next — there is no EU instrument for them to differ from. Member states that have acted have had to legislate from scratch, and several have told the Commission so in trade-barrier notifications.
The UK has since drawn the line explicitly, in one Act. The Tobacco and Vapes Act 2026 creates offences for snus — “It is an offence to manufacture a relevant oral tobacco product.”, with parallel offences for selling it and for “possession with intent to supply it to another in the course of business” — and defines the target as a tobacco product that is intended for oral use, is not intended to be inhaled or chewed, and “consists wholly or partly of tobacco in powder or particulate form.” In the same Act, a pouch is not that. It is a “nicotine product”, and the rule for it is an age limit: “It is an offence to sell a vaping product or nicotine product to a person who is under the age of 18.” Both came into force together, six months after Royal Assent on 29 April 2026, so 29 October 2026 — the Act never prints that date, you derive it from its commencement section.
In Sweden, one is governed as a food and the other is not
Sweden regulates snus through food law, which sounds like a curiosity and is actually the reason Swedish snus is a cleaner product than American moist snuff. The Food Act lists, among things equated with food, “snus, snusliknande produkter och tuggtobak.” — snus, snus-like products and chewing tobacco. The verb is jämställs, “is equated with”, not “is”, and the food authority is blunt about why: “Snus, snusliknande produkter och tuggtobak är inte livsmedel enligt definitionen av livsmedel i artikel 2 i förordning (EG) nr 178/2002.” — these are not food under EU law; the equation is a domestic legal-technical device for borrowing selected parts of food legislation.
What gets borrowed is strict. The food authority’s own regulation, LIVSFS 2024:2, allows only additives from an annexed list — “Endast de livsmedelstillsatser som anges i bilagan till dessa föreskrifter får ingå i snus och tuggtobak.” — permits only flavourings allowed in food, imposes drinking-water quality on the water used, and sets numeric ceilings including “NNN och NNK (summan) i mängder över 2 mg/kg torrvikt.” for tobacco-specific nitrosamines. It also requires the can to say what it is: “Förpackningar med snus eller tuggtobak som levereras direkt till konsument ska förses med varans beteckning: snus eller tuggtobak.”
Read the splits inside that regulation carefully, because they are the sharpest legal distinction between the two products anywhere. The lead, aflatoxin and benzo(a)pyrene ceilings apply to snus-like products, pouches included. The nitrosamine ceiling applies only to snus och tuggtobak. Sweden’s nitrosamine limit is a snus limit, and a tobacco-free pouch is outside it — which is logical, since there is no tobacco to carry nitrosamines, but it means the number is not a guarantee about pouches.
Pouches get their own statute, Lag (2022:1257), which never once uses the word snus. It defines “tobaksfri nikotinprodukt: en produkt utan tobak som innehåller nikotin för konsumtion”, requires notification “senast sex månader innan” the product reaches consumers, and requires an ingredient declaration and health warning on the pack. It sets no strength limit at all — I searched all 27,058 bytes for nikotinhalt, mg/g and gränsvärde and found none. And it forbids a pouch label from implying “att en viss tobaksfri nikotinprodukt är mindre skadlig än andra sådana produkter” — that one pouch is less harmful than another pouch. Note the comparator: between pouches, not against cigarettes.
One more asymmetry worth knowing if you buy in Sweden: the tobacco act requires that “portionsförpackat snus ska innehålla minst 20 portioner.” — a can of portion snus must hold at least twenty. No such rule exists for pouches. And snus is exempt from the Swedish ban on referring to flavour or additives on tobacco packaging: “Förbudet mot att hänvisa till smak, doft eller tillsatser gäller dock inte snus.”
The United States: regulated as tobacco, taxed as nothing
This is the cleanest difference I found, and it holds up under checking.
On jurisdiction, both are tobacco products. The Food, Drug and Cosmetic Act definition at 21 U.S.C. § 321(rr)(1) reads: “The term “tobacco product” means any product made or derived from tobacco, or containing nicotine from any source, that is intended for human consumption”. FDA’s authority was extended to nicotine from any source with effect from 14 April 2022, which is why a synthetic-nicotine pouch is as much an FDA tobacco product as a can of snus.
On tax, they part company completely. The federal excise code at 26 U.S.C. § 5702 defines its chargeable categories: “The term “smokeless tobacco” means any snuff or chewing tobacco.” and “The term “snuff” means any finely cut, ground, or powdered tobacco that is not intended to be smoked.” Snus is snuff, and the rate is “On snuff, $1.51 per pound and a proportionate tax at the like rate on all fractional parts of a pound.” A tobacco-free pouch contains no powdered tobacco and no leaf tobacco, so it falls outside every chargeable category. The word nicotine appears exactly once in all 26,143 bytes of § 5702, in a 1958 amendment note about fertiliser and insecticide. No federal tobacco excise attaches to a tobacco-free pouch at all.
States have begun filling that gap product by product. Utah, for instance, taxes a nicotine pouch product as an “alternative nicotine product” at the sum of “$1” and “5 cents on each pouch contained within the alternative nicotine product in excess of 20 pouches” — a different regime from the one snus pays in the same state. I verified Utah; I have not run a fifty-state survey, so read that as one worked example rather than a national picture.
There is no EU-level tax asymmetry to match it, incidentally, because there is no EU tax treatment of either. Council Directive 2011/64/EU on tobacco excise covers cigarettes, cigars, cigarillos and smoking tobacco, and smoking tobacco must be smokable: “tobacco which has been cut or otherwise split, twisted or pressed into blocks and is capable of being smoked without further industrial processing;”. Searching the whole directive for snus, oral use, chewing, snuff, smokeless and nicotine returns zero hits for every term. Both products are taxed purely nationally, which is exactly why the Commission’s 2025 proposal to bring pouches into the excise structure mattered — and why Parliament’s rejection of it leaves a blank.
What is actually inside each
A pouch’s filler is a short list of food-grade materials. ZYN publishes its own: “In addition to nicotine salt, ZYN contains only food-grade ingredients.” followed by “NICOTINE SALT (Nicotine bitartrate dihydrate): Pharmaceutical-grade nicotine.” and a breakdown of cellulose fillers, pH adjusters and sweeteners. Velo states five ingredients and, unlike ZYN, states the nicotine source: “VELO is made with only 5 types of high-quality ingredients.” and states that its nicotine is “tobacco-free” and of pharmaceutical grade — a footnote marker interrupts that sentence in its own page source, and the footnote text is not resolvable on the page.
Snus is ground tobacco, water, salt, humectant, pH adjuster and flavouring, pasteurised rather than fermented — the difference that keeps nitrosamine formation down, covered in why Swedish snus is pasteurised and American snuff is fermented.
Two caveats on the “tobacco-free” label. First, in the only non-industry chemical comparison of the two categories, “only BRIDGE and FRĒ pouches contained racemic nicotine” while “The remaining ONPs and all OTPs contained 100% S-nicotine.” Racemic nicotine is the signature of synthetic manufacture; natural nicotine is a single enantiomer. Of ten brands marketed as tobacco-free, eight were chemically indistinguishable from tobacco-derived. FDA’s own order for ZYN records its nicotine source as tobacco. “Tobacco-free” means no tobacco leaf in the pouch, not nicotine made without tobacco.
Second, ZYN’s US FAQ never states where its nicotine comes from. Over 1.2 million bytes, tobacco-free, synthetic, derived from tobacco and tobacco leaf all return zero hits. And on the other side of the Atlantic a CDC paper puts the regulatory contrast plainly: “However, there are no FDA regulations defining standards for the ingredients used in TFN products.” Sweden sets a positive additive list and numeric contaminant ceilings for snus; the US sets no ingredient standards for pouches.
The chemistry that differs, and the chemistry that doesn’t
The real toxicological difference is nitrosamines, and it is large. In an analytical review funded by BAT — “This paper and the ONP studies discussed in the results section were funded entirely by BAT (Investments) Limited” — the measured NNN+NNK sum ran 0.69–0.81 µg/g in one set of three snus products and 0.33–0.35 µg/g in another set of two, against <0.01 µg/g across four pouches and <0.001 µg/g across eleven more. For reference, the industry’s own voluntary GothiaTek ceiling, reproduced in the same table, is 0.95 µg/g. Below the limit of reporting is not zero; it is not quantifiable. But the gap is one to three orders of magnitude, and it is the thing the tobacco-free formulation actually buys. Cadmium, lead, arsenic and acetaldehyde follow the same pattern.
Now the part that gets this comparison wrong in the other direction. People assume pouches are weaker, or stronger, as a category. On the measured chemistry they are neither. From the non-industry study: “Although ONPs contained, on average, 50% less nicotine than OTPs (6.4 ± 3.5 vs. 12.3 ± 8.2 mg/pouch, p < .001), they released similar amounts of nicotine within 5 minutes (ONPs 6.5 ± 3.9 vs. OTPs 7.6 ± 3.9 mg/pouch, p = .422).” And then the line that reframes everything: “However, per gram of pouch material, both ONPs and OTPs contained similar amounts of nicotine (14.6 ± 7.4 vs. 14.3 ± 8.2 mg/g, p = .487”.
Fourteen and a half milligrams per gram, in both. The whole per-pouch difference is mass. A snus portion is simply a bigger object. Where they do differ is in emptying: “Among OTPs, only Copenhagen, General, and Grizzly released at least 80% of their nicotine content after 5 minutes.”, and all the pouches released everything within an hour while roughly half the tobacco products did not.
Size and format, measured by a regulator
FDA holds filed dimensions for both categories, which lets this be exact rather than impressionistic. A ZYN Cool Mint 3 mg, from the appendix to its 2026 order: portion count 15, “Portion Mass: 0.40 g”, length “28 millimeters (mm)”, width 14 mm, thickness 4.5 mm, in a 6 g can. A General Dry Mint Portion Original Mini, from the snus review: 20 pouches, 300 mg portion mass, 28 mm × 14 mm × 5 mm, also in a 6 g can.
Identical footprint. The ZYN is the heavier of the two — 0.40 g against 0.30 g — and marginally thinner. A General Portion Original Large, by contrast, is 1,000 mg at 33 × 18 × 6 mm, two and a half times a ZYN’s mass. So “snus is bigger” is true of the large formats and false of the mini, and the format words are not specifications: see slim vs mini vs large.
Delivery: the one direct comparison is not publicly retrievable
I wanted to give you a single study that measured snus and a pouch in the same protocol. One exists — a pharmacokinetic comparison of ZYN against Swedish snus and American moist snuff — and I could not retrieve it: it is not in PubMed Central and the publisher refuses automated access. That is a real limitation of what follows.
What can be said from a pouch-only study, BAT-funded and using habitual snus users as subjects, is that nicotine from a pouch peaks at 60 to 65 minutes against 7 minutes for a cigarette, and that “Plasma nicotine concentration was not associated with the nicotine contents of the NPs.” Combine that with the in-vitro finding above — same nicotine per gram, same five-minute release, faster complete emptying from pouches — and the honest summary is that a snus portion and a pouch of comparable mass deliver comparably, with the pouch finishing sooner. For the detail, nicotine content in snus vs nicotine pouches goes through the numbers, and pouch weight vs nicotine content does the arithmetic.
The side-by-side
| Swedish snus | Nicotine pouch | |
|---|---|---|
| Contains tobacco | Yes — ground, pasteurised | No leaf tobacco; nicotine usually still tobacco-derived |
| EU status | Prohibited except Sweden, under Art. 17 TPD and the 1994 accession derogation | Not addressed by EU tobacco law at all; national rules only |
| UK status | Criminal to manufacture, sell or hold for supply, from 29 October 2026 | Lawful; age of sale 18 from the same date |
| US federal tax | $1.51 per pound as snuff | None — outside every chargeable category |
| US market authorisation | Lawful as a marketed tobacco product | Only 67 specific products may lawfully be sold |
| Swedish ingredient rules | Positive additive list, food flavourings only, TSNA ceiling of 2 mg/kg dry weight | Contaminant ceilings apply; the TSNA ceiling does not |
| NNN+NNK measured | 0.33–0.81 µg/g | Below reporting limit (<0.01 and <0.001 µg/g) |
| Nicotine per gram of material | 14.3 ± 8.2 mg/g | 14.6 ± 7.4 mg/g |
| Typical pouch mass | 0.3 g (mini) to 1.0 g (large) | 0.3–0.6 g measured; ZYN filed at 0.40 g |
| Minimum pouches per can (Sweden) | 20, by statute | No rule |
| Long-term epidemiology | Decades of Swedish cohort data | None yet |
What we don’t know, and the gap is one-sided
Neither product is safe and this site will not tell you otherwise. But the evidence positions are not symmetrical, and both halves deserve stating precisely.
For snus there is long-term data, and it is not a clean bill of health. A 2026 review in the Journal of Internal Medicine, publicly funded, puts it this way: “Snus use is not without cardiovascular risk and should not be assumed to be a safe alternative to cigarette smoking, given its independent associations with elevated CVD mortality, heart failure risk, and adverse postinfarction prognosis.” The same review adds a caveat that cuts the other way, though: “Importantly, TSNA levels have declined substantially over several decades, meaning that older epidemiological studies were conducted at a time when constituent levels were considerably higher than today”. The decades of evidence describe a dirtier product than today’s snus.
For pouches there is essentially nothing. The same review notes that Sweden’s cohort infrastructure is only now positioned to generate the first long-term evidence on pouches, “though any such analyses will require careful consideration of the limited follow”-up currently available. An NIH- and FDA-funded scoping review is blunter: “ONPs may be a less hazardous alternative to traditional tobacco, but they are not risk-free.”
And the EU’s governing scientific opinion on oral tobacco, which concluded that “STP are addictive and their use is hazardous to health.”, was adopted in February 2008. I searched its full text: nicotine pouch appears zero times and tobacco-free zero times, against 417 occurrences of snus. Europe’s standing scientific assessment of oral nicotine predates the pouch entirely.
One regulator has made a comparative finding, and it is worth reading for its scope rather than its headline. FDA granted Swedish Match a modified-risk claim for General Snus — “Using General Snus instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis” — and in June 2026 granted ZYN a claim whose text is identical but for the brand name. Both are closed lists of six named conditions, both are conditional on substituting completely for cigarettes, and neither says anything about one of these products against the other.
Frequently asked questions
Are nicotine pouches just tobacco-free snus?
In shape and use, nearly. In law, no: one is a prohibited tobacco product across most of the EU and the other is barely mentioned in EU law. In chemistry the pouch is substantially cleaner on nitrosamines and metals, and essentially identical on nicotine per gram.
Which is stronger?
Per pouch, snus, because the pouches are heavier — the measured averages were 12.3 against 6.4 mg. Per gram of material they are the same. What reaches your blood tracks neither number reliably.
Can I buy snus outside Sweden?
Not lawfully in the EU outside Sweden, and in the UK manufacture, sale and possession with intent to supply are offences from 29 October 2026. In the United States snus is lawful and taxed as snuff.
Is “tobacco-free” marketing or fact?
Fact about the pouch contents, marketing if read as being about the nicotine. In the only independent chirality test, eight of ten tobacco-free-labelled brands contained nicotine indistinguishable from tobacco-derived, and FDA’s own filing for ZYN records the nicotine source as tobacco.
Does the Swedish nitrosamine limit protect pouch users?
No, and this is a detail almost nobody has noticed. LIVSFS 2024:2 applies lead, aflatoxin and benzo(a)pyrene limits to snus-like products including pouches, but confines the 2 mg/kg nitrosamine ceiling to snus and chewing tobacco.
See also why Norwegian snus is different from Swedish snus.
Sources
- Directive 2014/40/EU, Articles 2(8) and 17 and recitals 23 and 32, read from the UK’s archived consolidated copy. This is the National Archives’ EU-exit mirror, not EUR-Lex, which refuses automated requests. Tobacco and Related Products Regulations 2016, reg. 17.
- Tobacco and Vapes Act 2026, ss. 7–10, 51 and 175 — the oral-tobacco offences, the nicotine product definition, and the commencement provision from which the 29 October 2026 date is derived.
- Council Directive 2011/64/EU, Articles 2 and 5, same archive — no smokeless category.
- Livsmedelslag (2006:804), 3 §; Lag (2018:2088) om tobak och liknande produkter; Lag (2022:1257) om tobaksfria nikotinprodukter.
- LIVSFS 2024:2 (Livsmedelsverket, in force 1 April 2024) — additive list, flavourings, contaminant and nitrosamine ceilings, designation. Kontrollwiki article 887 — snus is not food under EU law.
- 21 U.S.C. § 321(rr); 26 U.S.C. § 5702; 26 U.S.C. § 5701(e) (US Code, 2024 edition). Utah Code § 59-14-804, effective 1 July 2026.
- FDA, modified risk tobacco product order for ZYN, 30 June 2026, including the Appendix A product attributes; FDA Technical Project Lead review, General Snus MRTP renewal — per-SKU snus dimensions and the General Snus claim. FDA’s authorised pouch list, content current 30 October 2026.
- Page MK et al., Nicotine & Tobacco Research 28(2):268, 2026 — PMC12824957, NCI-funded: nicotine per pouch and per gram, release kinetics, chirality.
- “Scientific assessment of oral nicotine pouches and associated risk reduction in comparison to combustible cigarettes”, Toxicology Reports, PMC13717000 — the snus-versus-pouch analyte table, which also reproduces the GothiaTek voluntary limits. Funded entirely by BAT. McEwan M et al., PMC8917032 — pouch pharmacokinetics. BAT-funded.
- CDC authors, Tobacco Control, PMC12075619 — no FDA ingredient standards for tobacco-free nicotine products; no specific grant declared.
- PMC13641279 (Journal of Internal Medicine, Knowledge Foundation grant, no declared conflicts) and PMC13660210 (NIH/NCI and FDA grant 2U54CA229974) — the evidence gap on both sides.
- SCENIHR, Health Effects of Smokeless Tobacco Products, adopted 6 February 2008 — searched in full; contains no reference to nicotine pouches.
- Manufacturer ingredient statements, read 6 November 2026: ZYN US FAQ, Velo.
- Last verified 6 November 2026.
